Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2507-2514

  Anber, V ^a   Millar, J S ^a   McConnell, M ^a   Shepherd, J ^a   Packard, C J ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atherogenic lipoprotein phenotype; Ciprofibrate; LDL subfractions; Sialic acid

Indexed keywords

APOLIPOPROTEIN B; ARGININE; CHOLESTEROL; CIPROFIBRATE; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYSINE; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; SIALIC ACID; SIALIDASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031472257     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2507     Document Type: Article

References (18)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
2. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Manttan M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317:1237-1245.
3. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results: I. Reduction in increase of coronary heart disease; II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:351-374.
4. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy, Berenson GS. Interaction of serum lipoproteins and a proteoglycan from bovine aorta. J Biol Chem. 1981;256(15):8234-8241.
5. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis. 1988; 8:851-857.
6. Camejo G, Acquatela H, Lalaguna F. The interaction of low density lipoprotein with arterial proteoglycans: an additional risk factor? 63 Atherosclerosis. 1980;36:55-65.
7. Srinivasan SR, Vijayagopal P, Ebrele K, Radhakrishnamurthy B, Berenson GS. Low density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulphate proteoglycan subfraction. Biochem Biophys Acta. 1989;1006:159-166.
8. Olsson U, Camejo G, Bonjers G. Binding of a synthetic lipoprotein B-100 peptide and peptide analogues to chondroitin-6-sulfate: effects of lipid environment. Biochemistry. 1993;32:1858-1865.
9. Camejo G, Lopez A, Lopez F, Quinones J. Interaction of low density lipoprotein with arterial proteoglycans: the role and charge of sialic acid content. Atherosclerosis. 1985;55:93-105.
10. Linden T, Bondjers G, Camejo G, Bergstran R, Wilhelmsen L, Wiklund O. Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction. Eur J Clin Invest. 1989;19:38-44.
11. Camejo G, Eva-Hurt Camejo, Romano M. Properties of lipoprotein complexes isolated by affinity chromatography from human aorta. Biomed Biochem Acta. 1985;44:3:389-401.
12. Srinivasan SR, Dolan P, Radhakrishnamurthy B, Pargaonkar PS, Berenson GS. Lipoprotein-acid muccopolysacchride complexes of human atherosclerotic lesions. Biochim Biophys Acta. 1975;388: 58-70.
13. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis. 1996;124:261-271.
14. f 60-400 lipoproteins between plasma and arterial intima in humans. Arterioscler Thromb. 1991; 11:569-577.
15. Nordestgaasd BG, Tybjaerg-Hansen A, Lewis B. Influx in-vivo of low density and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Arterioscler Thromb. 1992; 12:6-18.
16. Nordesgaard BG, Nielsen LB. Atherosclerosis and arterial influx of lipoproteins. Curr Opin Lipidol. 1994;5:252-257.
17. Gianturco SH, Bradley WA. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 1994;5:313-315.
18. Mahley RW, Weisgraber KH, Innerarity TL. Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors. Biochim Biophys Acta. 1979;575:81-91.